Healthcare delivery is steadily migrating from hospital wards into living rooms, and new market data captures the scale of that shift. According to the latest research on the Home Healthcare Market, global revenue is projected to grow from USD 251.12 billion in 2024 to USD 433.76 billion by 2031, representing a compound annual growth rate of 8.12%. The market, valued at USD 234.51 billion in 2023, is being propelled primarily by an aging global population, rising chronic disease prevalence, and a growing preference for personalized, cost-effective care delivered outside institutional settings.
An Aging World Reshapes Healthcare Delivery
The demographic forces behind this growth are stark. Global health authorities project that by 2030, one in six people worldwide will be aged 60 or older, with that population expected to reach 1.4 billion. By 2050, this figure is projected to double to 2.1 billion, while the population aged 80 and above is expected to triple to 426 million. Older adults, particularly those managing chronic conditions and mobility limitations, require ongoing medical attention — and increasingly, they and their families are choosing to receive that care at home rather than in institutional settings.
Major companies serving this market include Abbott, Sunrise Medical, Baxter Health, Medtronic, Cardinal Health, F. Hoffmann-La Roche, Air Liquide Sante International, Amedisys, Arkray, and OMRON Healthcare. These companies span a wide spectrum of home healthcare needs, from therapeutic and diagnostic products to mobility care equipment and skilled nursing services.
Cost-Effectiveness Accelerates the Shift Away From Institutions
Affordability is a central driver reshaping how healthcare is delivered. As institutional care costs continue to climb, home healthcare offers a compelling alternative that can reduce hospital readmissions, lower overhead expenses, and minimize the need for extended institutional stays. This value proposition resonates with both patients seeking personalized care and insurers looking to manage costs while maintaining quality outcomes.
This dynamic is playing out concretely in emerging markets as well as mature ones. In India, for example, a major insurer launched cashless home healthcare services across fifty cities, covering everything from medical fees to nursing, medication, and diagnostic testing — illustrating how insurers globally are recognizing home-based care as a strategic lever for cost containment and patient satisfaction alike.
Technology Integration Transforms Care Delivery
Telemedicine, remote monitoring, and AI-powered tools are fundamentally changing how home healthcare is delivered. These technologies allow healthcare professionals to monitor patients remotely, adjust treatment plans in real time, and diagnose emerging issues without requiring an in-person visit. Teleophthalmology and similar remote specialties are bridging geographic gaps in access, while AI tools are enhancing clinical decision-making and operational efficiency across the care continuum.
Notably, several companies have introduced generative AI platforms specifically tailored to homecare management, designed to streamline workflows, support remote monitoring, and reduce the administrative burden on healthcare professionals. This kind of technology integration is proving critical given the workforce pressures facing the industry — by automating routine tasks, these tools free up clinicians to focus more time on direct patient care.
Personalized Care Plans Gain Traction
Beyond remote monitoring, the industry is placing growing emphasis on truly personalized care. Providers are increasingly using data-driven insights and advanced analytics to build customized care plans tailored to individual patient needs, preferences, and lifestyle factors. One notable example is a healthcare experience platform launched to integrate patient data, engagement tools, and omnichannel communication, all aimed at improving care outcomes while reducing costs and enhancing the overall patient experience.
Segmentation: Cardiovascular Care and Skilled Nursing Lead
By indication, the market spans cardiovascular diseases, respiratory diseases, movement disorders, pregnancy, wound care, diabetes, and other conditions. Cardiovascular disease management led the segment in 2023, generating roughly USD 64.92 billion in revenue. Patients managing chronic heart conditions increasingly prefer receiving care at home, supported by remote patient monitoring, telemedicine consultations, and in-home rehabilitation services that ease the burden on hospital systems while improving patient satisfaction.
By service type, skilled nursing care captured the largest revenue share, at roughly 31.91% in 2023. Rising healthcare costs and hospital capacity constraints are pushing more patients toward in-home skilled nursing for post-operative care, chronic disease management, and rehabilitation, supported by technologies like remote monitoring and telehealth that allow nurses to deliver high-quality care while helping to reduce hospital readmission rates.
By product type, diagnostic products are expected to see especially strong growth, with a projected CAGR of 9.23% through the forecast period. This growth is being driven by technological advances and a heightened focus on early detection, as AI-powered diagnostic devices increasingly transform how conditions are identified and managed in home settings.
Workforce Shortages Remain a Central Challenge
Despite robust demand, the home healthcare industry faces a persistent challenge: recruiting and retaining skilled healthcare professionals such as nurses and therapists. High demand for services, combined with modest wages and burnout, has made staffing one of the sector’s most pressing constraints. Industry responses include offering more competitive compensation, improving work-life balance, and expanding career development opportunities — alongside deeper integration of telemedicine and remote monitoring tools that help alleviate the burden on an already stretched workforce.
Regional Analysis: North America Leads, Asia-Pacific Accelerates
North America accounted for the largest share of the global home healthcare market in 2023, at roughly 36.75%, or approximately USD 86.18 billion. The region’s dominant position reflects its aging population, advanced healthcare infrastructure, and high adoption of digital health technologies, reinforced by the presence of major home healthcare providers, favorable government policy, and broad insurance coverage.
Asia-Pacific, meanwhile, is projected to be the fastest-growing region, expanding at a CAGR of roughly 9.45% through 2031. Rapid growth is being driven by an aging population, rising healthcare awareness, and increasing demand for personalized care across countries such as China, India, and Japan. Advances in telemedicine, remote monitoring, and home-based diagnostics are transforming healthcare delivery throughout the region, supported by expanding healthcare infrastructure and government initiatives promoting home-based care.
Notable Industry Developments
Consolidation and expansion continue to reshape the competitive landscape. A major merger between two prominent home healthcare providers combined expertise in home infusion services with strength in home health, hospice, and high-acuity care, creating a broader national footprint capable of meeting rising demand from the aging population. Separately, a leading medical gas and home healthcare company expanded its European presence through acquisitions in Belgium and the Netherlands, adding capacity to support thousands of patients with respiratory and related treatments.
Outlook
With a projected CAGR of 8.12% through 2031, the home healthcare market is on track for sustained, demographically driven growth. As the global population continues to age and chronic disease prevalence rises, the combination of cost pressures, workforce innovation, and rapidly advancing remote care technology positions home healthcare as one of the most consequential shifts underway in global healthcare delivery.
